NISA INVESTMENT ADVISORS, LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 197 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$2,278
-96.4%
670
-92.3%
0.00%
Q2 2023$63,725
+70705.6%
8,6700.0%0.00%
-100.0%
Q1 2023$90
-89.4%
8,670
-87.9%
0.00%
-85.7%
Q4 2022$848
-99.5%
71,770
+723.8%
0.01%
+250.0%
Q3 2022$183,000
-80.4%
8,712
-71.1%
0.00%
-75.0%
Q2 2022$936,000
-22.7%
30,170
+2.3%
0.01%
-11.1%
Q1 2022$1,211,000
-10.4%
29,490
+2.1%
0.01%
-10.0%
Q4 2021$1,351,000
-14.4%
28,870
-8.4%
0.01%0.0%
Q3 2021$1,578,000
-15.1%
31,520
+6.8%
0.01%
-16.7%
Q2 2021$1,859,000
-34.7%
29,520
-3.6%
0.01%
-33.3%
Q1 2021$2,845,000
+7.9%
30,620
+4.1%
0.02%
+5.9%
Q4 2020$2,636,000
-15.6%
29,420
-2.6%
0.02%
-32.0%
Q3 2020$3,123,000
+35.4%
30,220
+3.6%
0.02%
+19.0%
Q2 2020$2,307,000
+23.6%
29,170
-9.5%
0.02%0.0%
Q1 2020$1,866,000
+7.2%
32,247
-0.1%
0.02%
+40.0%
Q4 2019$1,741,000
-0.9%
32,277
-4.0%
0.02%
-6.2%
Q3 2019$1,757,000
+26.8%
33,615
+17.1%
0.02%
+23.1%
Q2 2019$1,386,000
-4.4%
28,6950.0%0.01%
-7.1%
Q1 2019$1,450,000
-16.2%
28,695
-1.7%
0.01%
-26.3%
Q4 2018$1,731,000
-9.9%
29,1950.0%0.02%
+5.6%
Q3 2018$1,922,000
+30.4%
29,1950.0%0.02%
+20.0%
Q2 2018$1,474,000
-4.1%
29,1950.0%0.02%
-6.2%
Q1 2018$1,537,000
+3.4%
29,195
-8.7%
0.02%
+6.7%
Q4 2017$1,486,000
-0.3%
31,970
-13.3%
0.02%
-11.8%
Q3 2017$1,491,000
+20.7%
36,8700.0%0.02%
+13.3%
Q2 2017$1,235,000
+13.8%
36,870
-1.3%
0.02%
+15.4%
Q1 2017$1,085,000
-26.1%
37,370
-16.4%
0.01%
-27.8%
Q4 2016$1,468,000
+25.1%
44,700
+20.2%
0.02%
+20.0%
Q3 2016$1,173,000
+82.1%
37,200
+62.4%
0.02%
+66.7%
Q2 2016$644,000
-22.6%
22,9000.0%0.01%
-25.0%
Q1 2016$832,000
-9.2%
22,9000.0%0.01%
-7.7%
Q4 2015$916,000
+40.5%
22,9000.0%0.01%
+30.0%
Q3 2015$652,000
-9.7%
22,900
+4.6%
0.01%0.0%
Q2 2015$722,000
+54.9%
21,900
+35.2%
0.01%
+66.7%
Q1 2015$466,000
-16.5%
16,200
-21.0%
0.01%
-25.0%
Q4 2014$558,000
+69.1%
20,500
+32.3%
0.01%
+60.0%
Q3 2014$330,000
-11.1%
15,500
-6.1%
0.01%0.0%
Q2 2014$371,000
-11.0%
16,5000.0%0.01%
-16.7%
Q1 2014$417,000
+17.1%
16,500
+6.5%
0.01%
+20.0%
Q4 2013$356,00015,5000.01%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders